Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Myriad Genetics Inc (MYGN)

Myriad Genetics Inc (MYGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 479,770
  • Shares Outstanding, K 94,443
  • Annual Sales, $ 824,500 K
  • Annual Income, $ -365,900 K
  • EBIT $ -68 M
  • EBITDA $ 305 M
  • 60-Month Beta 1.86
  • Price/Sales 0.57
  • Price/Cash Flow 1.33
  • Price/Book 1.27

Options Overview Details

View History
  • Implied Volatility 92.11% (-10.51%)
  • Historical Volatility 61.18%
  • IV Percentile 25%
  • IV Rank 7.35%
  • IV High 586.89% on 02/19/26
  • IV Low 52.89% on 08/12/25
  • Expected Move (DTE 25) 0.82 (16.23%)
  • Put/Call Vol Ratio 0.11
  • Today's Volume 112
  • Volume Avg (30-Day) 62
  • Put/Call OI Ratio 0.38
  • Today's Open Interest 1,674
  • Open Int (30-Day) 1,329
  • Expected Range 4.26 to 5.90

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 13 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate $-0.17
  • Number of Estimates 4
  • High Estimate $-0.12
  • Low Estimate $-0.21
  • Prior Year $-0.14
  • Growth Rate Est. (year over year) -21.43%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.20 +20.95%
on 03/30/26
5.36 -5.22%
on 04/15/26
+0.30 (+6.28%)
since 03/17/26
3-Month
4.10 +23.90%
on 02/23/26
6.15 -17.40%
on 01/22/26
-0.84 (-14.19%)
since 01/16/26
52-Week
3.76 +35.11%
on 08/01/25
8.59 -40.86%
on 10/16/25
-2.56 (-33.51%)
since 04/17/25

Most Recent Stories

More News
Myriad Genetics to Deliver Six Abstracts, Including Two Podiums, at AACR 2026

SALT LAKE CITY, April 16, 2026 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, announced that it will share six abstracts,...

MYGN : 5.08 (+1.60%)
Myriad Genetics Expands Access for MyChoice Test to Prostate Cancer Patients in Japan

SALT LAKE CITY, April 14, 2026 (GLOBE NEWSWIRE) -- Myriad Genetics Inc. , (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced that Japan’s Ministry of...

MYGN : 5.08 (+1.60%)
1 Cash-Burning Stock to Target This Week and 2 We Question

1 Cash-Burning Stock to Target This Week and 2 We Question

IHRT : 4.10 (+9.63%)
MYGN : 5.08 (+1.60%)
SOFI : 19.43 (+2.10%)
Myriad Genetics Underscores Commitment to Cancer Care Continuum with New Data Presentations at SGO Annual Meeting

SALT LAKE CITY, April 09, 2026 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announces that it will share new data...

MYGN : 5.08 (+1.60%)
Q4 Earnings Highlights: Myriad Genetics (NASDAQ:MYGN) Vs The Rest Of The Therapeutics Stocks

Q4 Earnings Highlights: Myriad Genetics (NASDAQ:MYGN) Vs The Rest Of The Therapeutics Stocks

MYGN : 5.08 (+1.60%)
3 Healthcare Stocks with Open Questions

3 Healthcare Stocks with Open Questions

ENOV : 26.32 (+4.44%)
HSIC : 78.83 (+2.10%)
MYGN : 5.08 (+1.60%)
Elanco, Tandem Diabetes, Fortrea, Natera, and Myriad Genetics Shares Plummet, What You Need To Know

Elanco, Tandem Diabetes, Fortrea, Natera, and Myriad Genetics Shares Plummet, What You Need To Know

FTRE : 10.38 (+2.87%)
NTRA : 208.40 (+6.27%)
ELAN : 23.68 (+2.38%)
TNDM : 20.61 (+2.59%)
MYGN : 5.08 (+1.60%)
Myriad Genetics Receives FDA Approval of the MyChoice CDx Test as the Companion Diagnostic for Zejula (niraparib) for Patients with Ovarian Cancer 

SALT LAKE CITY, March 17, 2026 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced that the U.S. Food and Drug...

MYGN : 5.08 (+1.60%)
2 High-Flying Stocks with Competitive Advantages and 1 We Brush Off

2 High-Flying Stocks with Competitive Advantages and 1 We Brush Off

AAPL : 270.23 (+2.59%)
GLW : 164.38 (-1.02%)
MYGN : 5.08 (+1.60%)
Stocks making big moves yesterday: nLIGHT, Myriad Genetics, Vertex Pharmaceuticals, Nextpower, and Teladoc

Stocks making big moves yesterday: nLIGHT, Myriad Genetics, Vertex Pharmaceuticals, Nextpower, and Teladoc

TDOC : 5.69 (-2.23%)
LASR : 70.43 (+1.37%)
MYGN : 5.08 (+1.60%)
VRTX : 441.20 (+1.27%)
NXT : 111.39 (+4.27%)

Business Summary

Myriad Genetics employs a number of proprietary technologies to target the genetic basis of human diseases and the role these genes might play in the onset, progression and treatment of the respective diseases. The company has more than 10 proprietary molecular diagnostic products in market. It has made...

See More

Key Turning Points

3rd Resistance Point 5.48
2nd Resistance Point 5.38
1st Resistance Point 5.23
Last Price 5.08
1st Support Level 4.98
2nd Support Level 4.88
3rd Support Level 4.73

See More

52-Week High 8.59
Fibonacci 61.8% 6.74
Fibonacci 50% 6.18
Fibonacci 38.2% 5.61
Last Price 5.08
52-Week Low 3.76

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.